NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/14/2026
Back to search
Official data from USPTO
EBESANAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
EBESANAR
ST13
US500000079365162Class
1, 5, 42, 44
Filing
79365162
Registration
7470205
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
05/15/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
12/07/2022
Registration date
08/13/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2024
Last transaction
05/15/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
28
Owner location
DD
Examiner
CERDA, VICTOR
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
RHEACELL GmbH & Co. KG
Representatives
Sean K. Owens Wood Herron & Evans LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cells for scientific use; stem cells for research use; cell growth media for growing cells for scientific use; stem cells other than for medical or veterinary purposesstem cells for aesthetic purposes excluding all medical or veterinary purposes
Class 5
Drugs for medical purposespharmaceutical preparations for treating skin disorders; pharmaceutical and veterinary preparationspharmaceutical preparations for treating skin disorders; diagnostic agentsdiagnostic radiopharmaceutical agent for use in PET imaging; pharmaceutical preparationspharmaceutical preparations for treating skin disorders; preparations for medical purposespharmaceutical preparations for treating skin disorders; preparations for biomedical purposespharmaceutical preparations for treating skin disorders; pharmaceutical cell preparations for treating skin disorders; substances for medical usepharmaceutical preparations for treating skin disorders; substances for biomedical purposespharmaceutical preparations for treating skin disorders; live implants for pharmaceutical purposesimplants comprising living tissue for pharmaceutical purposes; biochemical and chemical products for medical usepharmaceutical preparations for treating skin disorders; biochemical and chemical products for pharmaceutical purposespharmaceutical preparations for treating skin disorders; biochemical and chemical diagnostic preparations for medical purposes; proteins for medical purposesprotein arrays for medical diagnosis purposes; biological preparations for medical and veterinary purposespharmaceutical preparations for treating skin disorders; pharmaceutical and veterinary preparations for external and systemic usepharmaceutical preparations for treating skin wounds; biologicalpharmaceutical and veterinary preparations for skin care for medical purposespharmaceutical preparations for treating skin disorders; medical dressings; preparations for wound treating and healingpharmaceutical preparations for treating skin wounds; pharmaceutical preparations for treating skin wounds; stem cells for medical purposes; stem cells for veterinary purposes; somatic stem cell therapeuticssomatic stem cells for medical or veterinary use; cells for medical use in the nature of fibroblasts for medical purposes; cells for medical use in the nature of fibroblasts for surgical beauty purposes; pharmaceutical implantsimplantable pharmaceutical preparations for treating cancer; cells for medical use in the nature of surgical implants derived from stem cells; cells for medical use in the nature of surgical implants derived from fibroblasts; cells for medical use in the nature of biological tissue for implantation; growth media for culturing cells for medical purposes; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissueliving cells for medical use; biotechnologically engineered tissue productscells for medical use
Class 42
Pharmaceutical drug development; scientific and technological servicesscientific research in the field of genetics; research and development services in the fields of cell diagnosticscell therapy; scientific research for medical purposes in the field of genetics; stem cell research services; scientific research; scientific research and development; scientific researchtesting and analysis services in the field of genetics; medical research; biomedical research services; research and development in the field of biotechnology; research and development in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development of new products; industrial process researchresearch and development of new products; research and development of new products for the pharmaceutical industry; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information about medical and scientific research for pharmaceutical products; preparation of reports relating to scientific research
Class 44
Medical services; medical diagnostic testingmonitoring and reporting services; medical assistance; health clinic services; hospital services; plastic and cosmetic surgery; medical therapiesproviding laser therapy for treating medical conditions; medical services in the field of regenerative medicine; medical services relating to the cultivation and procurement of stem cells; medical services in connection with the cultivation and procurement of stem cells
Publications
History of USPTO decisions and trademark events.
23 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/22/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/04/2025
FIMP
FINAL DISPOSITION PROCESSED
02/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/13/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/13/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/28/2024
PUBO
PUBLISHED FOR OPPOSITION
05/28/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/17/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/17/2024
RFNT
REFUSAL PROCESSED BY IB
11/13/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/24/2023
RFRR
REFUSAL PROCESSED BY MPU
10/24/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/14/2023
CNRT
NON-FINAL ACTION WRITTEN
10/13/2023
DOCK
ASSIGNED TO EXAMINER
09/13/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/16/2023
Continuous trademark protection
Get notified about every new filing that threatens EBESANAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.